Samsung has officially announced that the Irregular Heart Rhythm Notification (IHRN) feature of the Samsung Health Monitor app has now finally received FDA clearance. With the ECG feature, the IHRN feature monitors heart rhythms suggestive of atrial fibrillation (AFib).
“We’re excited to announce that Irregular Heart Rhythm Notification, designed to help millions of people around the world who may not be aware of a potential heart risk, has been cleared by the FDA,” said Hon Pak, Vice President and Head of the Digital Health Team, MX Business at Samsung Electronics. “This is yet another example of how Samsung prioritizes proactive safety solutions and enables users to receive a more holistic understanding of their cardiovascular and overall health.”
As we know that these days issues related to Cardiovascular disease remain the main reason for death and AFib which is a type of arrhythmia — is widely considered a warning sign for major cardiovascular issues that can increase the risk of stroke, heart failure and other cardiovascular complications.
To prevent it Samsung Galaxy Watch offers special tools to help users better understand their heart health using the Samsung BioActive Sensor, including on-demand ECG recording and HR Alert function that detects abnormally high or low heart rates. The addition of the new IHRN feature enables Galaxy Watch 4 and 5 users to monitor another aspect of their health.
Availability of the IHRN Feature in Samsung Galaxy Watch
According to the latest information, this new Irregular Heart Rhythm Notification feature will be available with One UI 5 Watch and it is officially arriving later this year.
FOLLOW US ON – Telegram and Google News
